Azithromycin News and Research

RSS
Azithromycin, also known as Zithromax, belongs to the class of medicines known as antibacterials orantibiotics. These medicines kill bacteria (small organisms that can cause infection in humans) or stopbacteria from growing. Patients with weakened immune systems, includingpeople with HIV, tend to have more frequent andmore serious bacterial infections. Azithromycinwas approved by the FDA on June 14, 1996, formany uses, including the prevention and treatmentof Mycobacterium avium complex (MAC) inpersons with advanced HIV infection. It is alsobeing investigated to see how well it works inpreventing other kinds of bacterial infections inpeople with HIV.
Phase 3 trial finds corticosteroid inhaler speeds recovery time in COVID-19 patients

Phase 3 trial finds corticosteroid inhaler speeds recovery time in COVID-19 patients

Hydroxychloroquine has no effect in treating people with COVID-19, study shows

Hydroxychloroquine has no effect in treating people with COVID-19, study shows

Five herbal medicines show potent activity against Babesia duncani in the lab

Five herbal medicines show potent activity against Babesia duncani in the lab

Study calls for continuous monitoring of dark web marketplaces in view of vaccines shortage

Study calls for continuous monitoring of dark web marketplaces in view of vaccines shortage

Ivermectin may not be the ‘silver bullet’ antiviral against COVID-19

Ivermectin may not be the ‘silver bullet’ antiviral against COVID-19

Study shows that single water molecule may cause antibiotic resistance

Study shows that single water molecule may cause antibiotic resistance

Are antibiotic regimens for critical COVID-19 patients with bacterial superinfection unnecessarily high?

Are antibiotic regimens for critical COVID-19 patients with bacterial superinfection unnecessarily high?

Azithromycin trial fails to provide evidence of benefit in COVID-19

Azithromycin trial fails to provide evidence of benefit in COVID-19

Remdesivir likely to be highly effective treatment for COVID-19

Remdesivir likely to be highly effective treatment for COVID-19

Researchers use AI platform to identify best combination of available therapies against COVID-19.

Researchers use AI platform to identify best combination of available therapies against COVID-19.

Using AI to find optimal combination of available therapies against SARS-CoV-2

Using AI to find optimal combination of available therapies against SARS-CoV-2

Chloroquine/hydroxychloroquine could treat COVID-19 infection

Chloroquine/hydroxychloroquine could treat COVID-19 infection

Excessive use of antibiotics during COVID-19 pandemic could intensify drug resistance

Excessive use of antibiotics during COVID-19 pandemic could intensify drug resistance

Steam inhalation therapy found to inactivate SARS-CoV-2 virions

Steam inhalation therapy found to inactivate SARS-CoV-2 virions

Scientists investigate how cell membrane and COVID-19 virus impact each other

Scientists investigate how cell membrane and COVID-19 virus impact each other

Drugs targeting neutrophils could reduce ARDS in severe COVID-19

Drugs targeting neutrophils could reduce ARDS in severe COVID-19

Aspirin to be tested as a potential COVID-19 treatment as part of RECOVERY trial

Aspirin to be tested as a potential COVID-19 treatment as part of RECOVERY trial

Study suggests honey and Nigella sativa expedites viral clearance in COVID-19 patients

Study suggests honey and Nigella sativa expedites viral clearance in COVID-19 patients

Hydroxychloroquine not associated with prolonged heart rhythm intervals in RA or lupus patients

Hydroxychloroquine not associated with prolonged heart rhythm intervals in RA or lupus patients

Fight against trachoma disrupted by COVID-19 pandemic

Fight against trachoma disrupted by COVID-19 pandemic